INDUSTRIAL POLICY AND “NEW NORMALITY” by N. M. Abdikeev, A. Yu. Teplyakov

Get full text

TOWARD THE QUESTION OF ISCHEMIC MYOCARDIAL DYSFUNCTION by V. V. Kalyuzhin, A. T. Teplyakov, I. D. Bespalova, Ye. V. Kalyuzhina

Get full text

THE TARGET INDICATORS OF THE ELEVATION OF COMPETITIVENESS OF MANUFACTURING BRANCHES IN RUSSIAN FEDERATION by N. M. Abdikeev, Yu. S. Bogachev, E. L. Moreva, A. Yu. Teplyakov

Get full text

Estimation of blood supply of the sternum after operations on the chest wall by S. E. Mamchur, V. I. Chernov, A. T. Teplyakov, Yu. Yu. Vechersky, N. G. Krivonogov

Get full text

LONG-TERM EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION AT THE BACKGROUND OF MULTIPLE-... by M. N. Sin’kova, T. V. Pepelyaeva, L. K. Isakov, N. I. Tarasov, A. T. Teplyakov

Get full text

Pathogenesis of chronic heart failure: change of dominating paradigm by V. V. Kalyuzhin, A. T. Teplyakov, Yu. Yu. Vechersky, N. V. Ryazantsevа, A. P. Khlapov

Get full text

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction by E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin

Get full text

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION by A. T. Teplyakov, E. V. Grakova, E. N. Berezikova, S. N. Shilov, K. V. Kopeva, V. V. Kalyuzhin

Get full text

Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction by A. T. Teplyakov, D. Yu. Kamaev, V. V. Kalyuzhin, Ye. Yu. Pushnikova, Ye. V. Kalyuzhina, T. A. Stepacheva

Get full text

Cardiology Research Institute, Tomsk National Research Medical Center by E. V. Grakova, K. V. Kopyeva, A. T. Teplyakov, L. K. Isakov, M. N. Sinkova, N. I. Tarasov

Get full text

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE by N. I. Tarasov, M. N. Sinkova, L. K. Isakov, N. B. Lebedeva, V. A. Shilov, A. T. Teplyakov

Get full text

REMODELING OF THE LEFT VENTRICLE: ONE OR SEVERAL SCENARIOS? by V. V. Kalyuzhin, A. T. Teplyakov, M. A. Solovtsov, E. V. Kalyuzhina, I. D. Bespalova, N. N. Terentyeva

Get full text

Prognostic role of neutrophil gelatinase-associated lipocalin in patients with coronary artery disease and abdominal obesity by A. V. Svarovskaya, P. A. Astanin, A/ T. Teplyakov, A. D. Vende, O. N. Ogurkova, A. A. Garganeeva

Get full text

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocar... by E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko

Get full text

Prognostic value of humoral markers in patients with anthracycline-related cardiac dysfunction by E. V. Grakova, K. V. Kopeva, S. N. Shilov, E. T. Bobyleva, E. N. Berezikova, V. V. Kalyuzhin, A. T. Teplyakov

Get full text

FGB, TNFα, IL-1β, LPL, ITGB3, and TGFB1 genes polymorphism in patients with recurrent myocardial infarction by S. D. Mayanskaya, L. A. Garaeva, A. T. Teplyakov, M. L. Filipenko, E. A. Sokolova, O. A. Kravtsova, E. V. Berezikova

Get full text

Characteristics of left ventricular and cardiac hemodynamic remodeling after on-pump or off-pump coronary artery bypass grafting by S. D. Mayanskaya, G. F. Abzalova, L. A. Garaeva, I. V. Abdulianov, A. T. Teplyakov, E. N. Berezikova, I. A. Grebenkina

Get full text

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? by A. T. Teplyakov, A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, V. V. Kalyuzhin

Get full text

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy by A. T. Teplyakov, S. N. Shilov, A. A. Popova, E. N. Berezikova, M. N. Neupokoeva, E. V. Grakova, K. V. Kopeva

Get full text

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability by E. V. Grakova, K. V. Kopeva, A. M. Gusakova, A. V. Smorgon, Sh. D. Akhmedov, V. V. Kalyuzhin, A. T. Teplyakov

Get full text